December 14, 2009

Contraindicated Medication Use in Dialysis Patients Undergoing Percutaneous Coronary Intervention

.   .   

This observational study identified that patients with renal failure undergoing PCI (percutaneous coronary intervention) frequently receive contraindicated anticoagulants such as enoxaparin and eptifibatide.  Such exposure was associated with an increased risk of in-hospital major bleeding.

Related Articles:

Internal Medicine for Nephrologists, Vascular Disease/Calcification

Comments are closed.